The Hidden Career Cost of Being Overweight

New moves to outlaw weight discrimination are prompting companies to investigate one of the deadliest forms…

WSJ News Exclusive | Noom Picks New CEO as It Moves Into Market for Ozempic

Geoff Cook will manage the digital-health platform as the company seeks to capitalize on the growing…

Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.

Companies developing weight-loss drugs have raised or signed deals worth more than $1.4 billion since about…

Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts

Ozempic is under review by European drug-safety regulators after reports of suicidal thoughts were linked to…

Obesity Drugs Won’t Starve These Other Potential Blockbusters

Shares of developers of fatty liver disease treatments were in decline until Eli Lilly published results…

Jenny Craig to Be Relaunched by Owner of Nutrisystem

The weight-loss brand was shuttered in May after four decades.

The Spying Scandal Inside One of America’s Biggest Power Companies

A private investigator surveilled the CEO of Southern Company, triggering an internal investigation into whether it…

Pill for Obesity Has Wall Street Salivating

Obesity treatment is currently limited to injections, but pills could expand the market and reduce costs.

No More Shots: Pill Versions of Ozempic-Like Drugs Are Coming

The pills may appeal to people who want to lose weight but hate the needles that…

Well-Funded Chains Muscle Into the Once-Niche World of Climbing Gyms

Small businesses are struggling to recover from the COVID-19 pandemic, while larger rivals are expanding into…